Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PSA assays

R J Ablin

    The Lancet. Oncology
    |March 22, 2002
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Immunosuppression by seminal plasma.

    Immunology today·2014
    Same author

    The role of neuroendocrine cells in prostate cancer: a comprehensive review of current literature and subsequent rationale to broaden and integrate current treatment modalities.

    Current medicinal chemistry·2013
    Same author

    Retinoids, vitamin D, invasion, and metastasis.

    Current oncology (Toronto, Ont.)·2012
    Same author

    The role of transglutaminases in the pathophysiology of prostate cancer.

    Current oncology (Toronto, Ont.)·2011
    Same author

    Screening for prostate cancer: Controversy? What controversy?

    Current oncology (Toronto, Ont.)·2009
    Same author

    An immune response: a possible caveat to endoscopic cryotherapy.

    Gastrointestinal endoscopy·2001
    Same journal

    Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial.

    The Lancet. Oncology·2026
    Same journal

    Trastuzumab rezetecan versus pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer (HORIZON-Breast01): interim analysis of a multicentre, open-label, randomised, controlled, phase 3 trial.

    The Lancet. Oncology·2026
    Same journal

    Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation Oncology.

    The Lancet. Oncology·2026
    Same journal

    European guideline for imaging of primary paediatric and adult osteosarcoma and Ewing sarcoma: systematic review and joint statement by the FOSTER consortium, Euro Ewing Consortium, European Society of Paediatric Radiology, and the European Association of Nuclear Medicine.

    The Lancet. Oncology·2026
    Same journal

    Novel strategies to overcome the blood-brain barrier in triple-negative breast cancer brain metastases.

    The Lancet. Oncology·2026
    Same journal

    Correction to Lancet Oncol 2025; 26: e369-80.

    The Lancet. Oncology·2026
    See all related articles